Dr. Glenn D. Steele, Jr. MD, is Independent Director at Cepheid, Independent Director at WellCare Health Plans, Inc., a Member at National Academy of Sciences, a Member at American College of Surgeons Oncology Group, a Member at American Society of Clinical Oncology, President & Chief Executive Officer at Geisinger Ventures, a Member at Institute of Medicine, a Member at New England Surgical Society, Chairman at xG Health Solutions, Inc., and a Member at American Surgical Association.
He is on the Board of Directors at PTC Therapeutics, Inc., Cepheid, WellCare Health Plans, Inc., Premier Plans LLC, Premier Healthcare Solutions, Inc., Bucknell University, Northeast Regional Cancer Institute, The Global Conference Institute, Healthcare Executives Network, Agency for Integrated Care Pte Ltd., and Ingenious Med, Inc.
Dr. Steele was previously employed as Chairman by Premier, Inc., Independent Director by Weis Markets, Inc., President & Chief Executive Officer by Geisinger Health System, an Advisor by Health Evolution Management Co. LLC, Chairman by American Board of Surgery, Dean by Pritzker School of Medicine, a Director-Research Committee by American Hospital Association, Inc., a Member by American Cancer Society, Inc., a Member by IMPATH, Inc., a Member by Society of Surgical Oncology, President & Chief Executive Officer by Geisinger Health System Foundation, a Professor by The University of Chicago Medical Center, a Professor by Harvard University, and Vice President-Medical Affairs by The University of Chicago.
He also served on the board at Harvard Medical Faculty Physicians, Millennium Health LLC, and Priority Healthcare Corp.
He received his undergraduate degree from Harvard College, a doctorate degree from the New York University School of Medicine, and a doctorate degree from the University of Lund.